Rani Therapeutics Holdings, Inc. (RANI) Income Tax Expense (Benefit) USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Rani Therapeutics Holdings, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • Rani Therapeutics Holdings, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $0.000, a 100% decline year-over-year.
  • Rani Therapeutics Holdings, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000, a 100% decline from 2022.
  • Rani Therapeutics Holdings, Inc. annual Income Tax Expense (Benefit) for 2022 was $70 K, a 70.7% increase from 2021.
  • Rani Therapeutics Holdings, Inc. annual Income Tax Expense (Benefit) for 2021 was $41 K, a 17.1% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 -$70 K -100% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 $70 K +$29 K +70.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $41 K +$6 K +17.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $35 K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.